Quote:

---

The release of what Strayhorn was doing in regards to Cytodyn was a black eye to the FDA. They wouldn't dare keep her on Cytodyn's case. Being a civil servant unfortunately it would be an uphill battle for the FDA to fire her.

---

Assuming you are right (not a bad assumption), that's very good news. We didn't hear any public utterances from the FDA on the subject, but presumably they were paying attention.